Biohit Oyj - Company Announcement

Biohit Concludes Statutory Co-operation Negotiations

Main Market, 2012-10-01 11:00 CEST (GLOBE NEWSWIRE) -- Biohit Oyj stock
exchange release, 1 October 2012 at EET 12:00 am 

The statutory co-operation negotiations concerning Biohit employees in Finland
that started in September 2012 have been concluded today. As a result of
co-operation negotiations, the company has decided to execute operative
savings, modify job descriptions and to reduce two people to achieve cost
savings. The decisions made in and during the statutory co-operation
negotiations will generate EUR 310.000 savings on an annual level. “I thank the
staff representatives for their constructive contribution in these statutory
co-operation negotiations”, says Semi Korpela, CEO, Biohit Oyj. 

Biohit offers an outplacement program for people impacted by the co-operation
negotiations. 



Contact details:
Semi Korpela, M. Sc. Econ., President & CEO
Biohit Oyj, tel.: +358 9 773 861, semi.korpela@biohit.fi


Biohit Oyj is a globally operating Finnish biotechnology company that was
established in 1988. Biohit's mission is “Innovating for Health” and “Cancer
Prevention”. The purpose of the company is to produce innovation, new
technologies and analysis systems for use in medicine, research institutions
and industry, helping to promote research and diagnostics and to improve the
quality of life of people by means of preventing disease, human suffering and
financial loss. Our duty is also to innovate and develop the marketing and
availability of our products and services. www.biohithealthcare.com